These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 8603569)

  • 21. Grb10 interacts differentially with the insulin receptor, insulin-like growth factor I receptor, and epidermal growth factor receptor via the Grb10 Src homology 2 (SH2) domain and a second novel domain located between the pleckstrin homology and SH2 domains.
    He W; Rose DW; Olefsky JM; Gustafson TA
    J Biol Chem; 1998 Mar; 273(12):6860-7. PubMed ID: 9506989
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of structural characteristics that contribute to a difference in antiapoptotic function between human insulin and insulin-like growth factor 1 receptors.
    Chen H; Yan GC; Gishizky ML
    Cell Growth Differ; 1998 Nov; 9(11):939-47. PubMed ID: 9831246
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Localization of the insulin receptor binding sites for the SH2 domain proteins p85, Syp, and GAP.
    Staubs PA; Reichart DR; Saltiel AR; Milarski KL; Maegawa H; Berhanu P; Olefsky JM; Seely BL
    J Biol Chem; 1994 Nov; 269(44):27186-92. PubMed ID: 7525547
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of phosphatidylinositol 3'-kinase by tyrosyl phosphoproteins. Full activation requires occupancy of both SH2 domains in the 85-kDa regulatory subunit.
    Rordorf-Nikolic T; Van Horn DJ; Chen D; White MF; Backer JM
    J Biol Chem; 1995 Feb; 270(8):3662-6. PubMed ID: 7876105
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential phosphorylation of IRS-1 by insulin and insulin-like growth factor I receptors in Chinese hamster ovary cells.
    Amoui M; Craddock BP; Miller WT
    J Endocrinol; 2001 Oct; 171(1):153-62. PubMed ID: 11572799
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insulin-stimulated oocyte maturation requires insulin receptor substrate 1 and interaction with the SH2 domains of phosphatidylinositol 3-kinase.
    Chuang LM; Myers MG; Backer JM; Shoelson SE; White MF; Birnbaum MJ; Kahn CR
    Mol Cell Biol; 1993 Nov; 13(11):6653-60. PubMed ID: 8413261
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potential involvement of FRS2 in insulin signaling.
    Delahaye L; Rocchi S; Van Obberghen E
    Endocrinology; 2000 Feb; 141(2):621-8. PubMed ID: 10650943
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence for a differential interaction of SHC and the insulin receptor substrate-1 (IRS-1) with the insulin-like growth factor-I (IGF-I) receptor in the yeast two-hybrid system.
    Tartare-Deckert S; Sawka-Verhelle D; Murdaca J; Van Obberghen E
    J Biol Chem; 1995 Oct; 270(40):23456-60. PubMed ID: 7559507
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tyrosine kinase activity of a chimeric insulin-like-growth-factor-1 receptor containing the insulin receptor C-terminal domain. Comparison with the tyrosine kinase activities of the insulin and insulin-like-growth-factor-1 receptors using a cell-free system.
    Mothe I; Tartare S; Kowalski-Chauvel A; Kaliman P; Van Obberghen E; Ballotti R
    Eur J Biochem; 1995 Mar; 228(3):842-8. PubMed ID: 7737184
    [TBL] [Abstract][Full Text] [Related]  

  • 30. p68 Sam is a substrate of the insulin receptor and associates with the SH2 domains of p85 PI3K.
    Sánchez-Margalet V; Najib S
    FEBS Lett; 1999 Jul; 455(3):307-10. PubMed ID: 10437794
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification by mutation of the tyrosine residues in the insulin receptor substrate-1 affecting association with the tyrosine phosphatase 2C and phosphatidylinositol 3-kinase.
    Rocchi S; Tartare-Deckert S; Mothe I; Van Obberghen E
    Endocrinology; 1995 Dec; 136(12):5291-7. PubMed ID: 7588273
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Essential role of tyrosine residues 1131, 1135, and 1136 of the insulin-like growth factor-I (IGF-I) receptor in IGF-I action.
    Kato H; Faria TN; Stannard B; Roberts CT; LeRoith D
    Mol Endocrinol; 1994 Jan; 8(1):40-50. PubMed ID: 7512194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Direct activation of the phosphatidylinositol 3'-kinase by the insulin receptor.
    Van Horn DJ; Myers MG; Backer JM
    J Biol Chem; 1994 Jan; 269(1):29-32. PubMed ID: 8276809
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phosphatidylinositol 3-kinase activation is mediated by high-affinity interactions between distinct domains within the p110 and p85 subunits.
    Holt KH; Olson L; Moye-Rowley WS; Pessin JE
    Mol Cell Biol; 1994 Jan; 14(1):42-9. PubMed ID: 8264609
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cloning of human p55 gamma, a regulatory subunit of phosphatidylinositol 3-kinase, by a yeast two-hybrid library screen with the insulin-like growth factor-I receptor.
    Dey BR; Furlanetto RW; Nissley SP
    Gene; 1998 Mar; 209(1-2):175-83. PubMed ID: 9524259
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential activation of insulin receptor substrates 1 and 2 by insulin-like growth factor-activated insulin receptors.
    Denley A; Carroll JM; Brierley GV; Cosgrove L; Wallace J; Forbes B; Roberts CT
    Mol Cell Biol; 2007 May; 27(10):3569-77. PubMed ID: 17325037
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interaction of the retinal insulin receptor beta-subunit with the p85 subunit of phosphoinositide 3-kinase.
    Rajala RV; McClellan ME; Chan MD; Tsiokas L; Anderson RE
    Biochemistry; 2004 May; 43(19):5637-50. PubMed ID: 15134438
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The C-terminal SH2 domain of p85 accounts for the high affinity and specificity of the binding of phosphatidylinositol 3-kinase to phosphorylated platelet-derived growth factor beta receptor.
    Klippel A; Escobedo JA; Fantl WJ; Williams LT
    Mol Cell Biol; 1992 Apr; 12(4):1451-9. PubMed ID: 1312663
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of a 60 kDa tyrosine-phosphorylated protein in insulin-stimulated hepatoma cells that associates with the SH2 domain of phosphatidylinositol 3-kinase.
    Milarski KL; Lazar DF; Wiese RJ; Saltiel AR
    Biochem J; 1995 Jun; 308 ( Pt 2)(Pt 2):579-83. PubMed ID: 7539611
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microinjection of the SH2 domain of the 85-kilodalton subunit of phosphatidylinositol 3-kinase inhibits insulin-induced DNA synthesis and c-fos expression.
    Jhun BH; Rose DW; Seely BL; Rameh L; Cantley L; Saltiel AR; Olefsky JM
    Mol Cell Biol; 1994 Nov; 14(11):7466-75. PubMed ID: 7935461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.